Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades

Abstract

This study investigated the accuracy of MRI features in differentiating the pathological grades of pancreatic neuroendocrine neoplasms (PNENs). A total of 31 PNENs patients were retrospectively evaluated, including 19 cases in grade 1, 5 in grade 2, and 7 in grade 3. Plain and contrastenhanced MRI was performed on all patients. MRI features including tumor size, margin, signal intensity, enhancement patterns, degenerative changes, duct dilatation and metastasis were analyzed. Chi square tests, Fisher’s exact tests, one-way ANOVA and ROC analysis were conducted to assess the associations between MRI features and different tumor grades. It was found that patients with older age, tumors with higher TNM stage and without hormonal syndrome had higher grade of PNETs (all P<0.05). Tumor size, shape, margin and growth pattern, tumor pattern, pancreatic and bile duct dilatation and presence of lymphatic and distant metastasis as well as MR enhancement pattern and tumor-topancreas contrast during arterial phase were the key features differentiating tumors of all grades (all P<0.05). ROC analysis revealed that the tumor size with threshold of 2.8 cm, irregular shape, pancreatic duct dilatation and lymphadenopathy showed satisfactory sensitivity and specificity in distinguishing grade 3 from grade 1 and grade 2 tumors. Features of peripancreatic tissue or vascular invasion, and distant metastasis showed high specificity but relatively low sensitivity. In conclusion, larger size, poorlydefined margin, heterogeneous enhanced pattern during arterial phase, duct dilatation and the presence of metastases are common features of higher grade PNENs. Plain and contrast-enhanced MRI provides the ability to differentiate tumors with different pathological grades.

Keywords

pancreatic neuroendocrine neoplasms / magnetic resonance imaging / WHO neuroendocrine tumor classification / TNM stage

References

[1] HalfdanarsonTR, RabeKG, RubinJ, et al. . Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol, 2008, 19(10): 1727-1733 PMID: 18515795 PMCID: 2735065

[2] ZhouC, ZhangJ, ZhengY, et al. . Pancreatic neuroendocrine tumors: a comprehensive review. Int J Cancer, 2012, 131(5): 1013-1022 PMID: 22437917

[3] MilanSA, YeoCJ. Neuroendocrine tumors of the pancreas. Curr Opin Oncol, 2012, 24(1): 46-55 PMID: 22080942

[4] BosmanFT, CarneiroF, HrubanRH, et al. . WHO classification of tumours of the digestive system, 2010, Lyon, IARC Press, 322-326

[5] RindiG, KloppelG, AlhmanH, et al. . TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 2006, 449(4): 395-401 PMID: 16967267 PMCID: 1888719

[6] GuntherRW, KloseKJ, RuckertK, et al. . Islet-cell tumors: detection of small lesions with computed tomography and ultrasound. Radiology, 1983, 148(2): 485-488 PMID: 6306722

[7] IchikawaT, PetersonMS, FederleMP, et al. . Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology, 2000, 216(1): 163-171 PMID: 10887243

[8] SemelkaRC, CustodioC C, BalciN, et al. . Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. JMRI, 2000, 11(2): 141-148 PMID: 10713946

[9] de HerderWW, KwekkeboomDJ, ValkemaR, et al. . Neuroendocrine tumors and somatostatin: imaging techniques. J EndocrinolI nvest, 2005, 28: 132-136

[10] ManfrediR, BonattiM, MantovaniW, et al. . Nonhyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour. Eur Radiol, 2013, 23(11): 3029-3039 PMID: 23793519

[11] KimDW, KimHJ, KimKW, et al. . Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol, 2015, 25(5): 1375-1383 PMID: 25465713

[12] TakumiK, FukukuraY, HigashiM, et al. . Pancreatic neuroendocrine tumors: Correlation between the contrastenhanced computed tomography features and the pathological tumor grade. Eur J Radiol, 2015, 84(8): 1436-1443 PMID: 26022520

[13] BushnellDL, BaumRP. Standard imaging techniques for neuroendocrine tumors. Endocrinol Metab Clin North Am, 2011, 40(1): 153-162 PMID: 21349416

[14] CaramellaC, DromainC, de BaereT, et al. . Endocrine pancreatic tumours: which are the most useful MRI sequences?. Euro Radiol, 2010, 20(11): 2618-2627

[15] HerwickS, MillerFH, KeppkeAL. MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol, 2006, 187(5): W472-W480 PMID: 17056877

[16] PanzutoF, FalconiM, NasoniS, et al. . Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy. Ann Oncol, 2003, 14(4): 586-591 PMID: 12649106

[17] DromainC, DeandreisD, ScoazecJY, et al. . Imaging of neuroendocrine tumors of the pancreas. Diagn Interv Imaging, 2016, 97(12): 1241-1257 PMID: 27876341

[18] GallottiA, JohnstonRP, BonaffiniPA, et al. . Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy. AJR, 2013, 200(2): 355-362 PMID: 23345357

[19] Marion-AudibertAM, BarelC, GouysseG, et al. . Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology, 2003, 125(4): 1094-1104 PMID: 14517793

[20] ZhangJ, JiaZ, LiQ, et al. . Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer, 2007, 109(8): 1478-1486 PMID: 17340592

[21] KimJH, EunHW, KimYJ, et al. . Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade. Abdom Imaging, 2013, 38(5): 1106-1114 PMID: 23728305

[22] RodallecM, VilgrainV, CouvelardA, et al. . Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology, 2006, 6(1-2): 77-85 PMID: 16327283

[23] XuLN, XuYY, GaoDW. Impact of operative and perioperative factors on the long-term prognosis of primary liver cancer patients undergoing epatectomy. J Huazhong Univ Sci Technol Med Sci, 2016, 36(4): 523-528 PMID: 27465327